ISSN: 1121-421X

Journal Home

Journal Guideline

Minerva Gastroenterologica e Dietologica Q3 Unclaimed

Edizioni Minerva Medica S.p.A. Italy

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Minerva Gastroenterologica e Dietologica is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism and Internal Medicine with an H index of 30. It has a best quartile of Q3. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Endocrinology, Diabetes and Metabolism (Q3) Gastroenterology (Q3) Internal Medicine (Q3) Nutrition and Dietetics (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Minerva Gastroenterologica e Dietologica

-

SJR Impact factor

30

H Index

9

Total Docs (Last Year)

150

Total Docs (3 years)

422

Total Refs

281

Total Cites (3 years)

103

Citable Docs (3 years)

1.83

Cites/Doc (2 years)

46.89

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Islets Q3
International Journal of Endocrinology Q3
Current Opinion in Endocrine and Metabolic Research Q3
Frontiers of Hormone Research Q3
European Endocrinology Q3

Compare this journals

Aims and Scope

Best articles by citations

Effectiveness of a nutraceutical supplement containing highly standardized perilla and ginger extracts in patients with functional dyspepsia

Assessing urban minority attitudes for colorectal cancer screening using financial incentives

Radiofrequency hemorrhoidectomy: less is less? Results of a comparative study

Efficacy of intestinal microbiota transplantation in ulcerative colitis: a review of current literature and knowledge

Management of Helicobacter pylori in Piedmont, Italy

Successful endoscopic closure of tracheoesophageal fistula using a Padlock ClipTM

Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease

Acute HCV infection after chemotherapy: the need to search for occult HCV before this treatment?

Anti-TNF combination therapy in inflammatory bowel disease: de novo or selective?

Negative payoffs of upper gastrointestinal endoscopy in patients admitted under observation status

Helicobacter pylori: what are the challenges of today and in the years to come?

Benign and malignant gastroduodenal diseases associated with Helicobacter pylori: a narrative review and personal remarks in 2018

SHOW MORE ARTICLES

The therapy of chronic pouchitis

Efficacy and safety of long-term entecavir therapy in a European population

Challenges and future developments in liver transplantation

Overlapping irritable bowel syndrome and inflammatory bowel disease

Oral iron supplementation with Feralgine¬Æ in inflammatory bowel disease: a retrospective observational study

Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases

Trimebutine: a state-of-the-art review

The role of microbiota in autism spectrum disorders

A place for probiotics and prebiotics in the studies on human microbiota and inflammatory bowel diseases

Oral administration of a lecithin-based delivery form of boswellic acids (Casperome¬Æ) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study

Long-term results of chronic hepatitis B antiviral treatment with nucleos(t)ide analogues: a single center experience

Liver stiffness-based model for portal hypertension and hepatocellular cancer risk in HBV responsive to antivirals